Difference between revisions of "Part:BBa K321003"
Line 6: | Line 6: | ||
<!-- Add more about the biology of this part here --> | <!-- Add more about the biology of this part here --> | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
+ | |||
+ | The CD3 zeta molecule activates immune T cells upon ligand binding to the T-Cell Receptor complex. The immunoreceptor tyrosine-based activation (ITAM) motifs in the intracellular domain of CD3 zeta recruits kinases that activate downstream molecules involved in cell signaling. This intracellular domain has been shown to function in a modular manner. It can be fused to different extracellular ligand binding domains to create functional synthetic receptors. | ||
===Function=== | ===Function=== | ||
− | This part was shown to activate killer cells. We | + | This part was shown to activate killer cells by the UCSF 2010 team. We successfully used this part in our proof of concept logic gate design for greater precision of killing towards cancer cells. The figure below shows that the part performs its activating function as expected: it activates killer cells in the presence of the intended ligand A that activates the synthetic receptor. For more information please see our <html><a href="http://2010.igem.org/Team:UCSF/Project/Precision#andn">wiki</a></html>. |
+ | |||
+ | <br> | ||
<html> | <html> |
Revision as of 21:08, 4 November 2010
intracellular chain of CD3 zeta
Encodes the intracellular signaling domain of the CD3 zeta molecule of the T-Cell Receptor complex. The sequence encodes the three ITAMs (Immunoreceptor tyrosine-based activation motif) that can activate immune cells.
Usage and Biology
The CD3 zeta molecule activates immune T cells upon ligand binding to the T-Cell Receptor complex. The immunoreceptor tyrosine-based activation (ITAM) motifs in the intracellular domain of CD3 zeta recruits kinases that activate downstream molecules involved in cell signaling. This intracellular domain has been shown to function in a modular manner. It can be fused to different extracellular ligand binding domains to create functional synthetic receptors.
Function
This part was shown to activate killer cells by the UCSF 2010 team. We successfully used this part in our proof of concept logic gate design for greater precision of killing towards cancer cells. The figure below shows that the part performs its activating function as expected: it activates killer cells in the presence of the intended ligand A that activates the synthetic receptor. For more information please see our wiki.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI site found at 274